ARTICLE | Clinical News
IntraBiotics starts Ramoplanin Phase III
June 29, 2000 7:00 AM UTC
IBPI began U.S. Phase III testing of its oral Ramoplanin inhibitor of gram-positive bacterial cell wall synthesis to reduce the incidence of bloodstream infections due to vancomycin-resistant enteroco...